Compare Quest Diagnostics Inc (DGX) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs United States Oil ETF — how do they compare? Quest Diagnostics Inc trades at $230.93 (market cap $25.48B), while United States Oil ETF trades at $148.66 (market cap $1.90B). The key difference: Quest Diagnostics Inc is far larger — about 13.4× United States Oil ETF's market cap, and Quest Diagnostics Inc pays a 1.49% dividend while United States Oil ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and United States Oil ETF for 21 Days on average.
| DGX | USO | |
|---|---|---|
Market Cap | $25.48B | $1.90B |
Volume | 941,866 | 5,932,922 |
Sector | Health | — |
52-Week High | $247.45 | $161.86 |
52-Week Low | $173.49 | $66.17 |
Typical Hold Time | 56 Days | 21 Days |
Enterprise Value | $31.23B | — |
Dividend Yield | 1.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.76, up 1.66% today, reflecting strong year-to-date momentum driven by consistent earnings beats and growth in advanced diagnostics. The stock is near its 52-week high with a consensus price target of $250, indicating further upside potential. Recent news highlights partnerships, such as integration with Apple Health, and clinical study successes, though Medicare reimbursement cuts pose a headwind. Technical indicators show a bearish signal overall, with support at $228 and resistance at $232.
The outlook remains positive due to robust revenue growth, expanding profit margins, and strategic initiatives, but risks include regulatory pressure on lab payments and rising debt levels. Analyst sentiment is mixed, with a majority holding neutral ratings, suggesting cautious optimism amid execution challenges and market volatility.
USO is trading at $148.32, up 3.06% today with a bullish technical signal supported by moving averages. The stock shows neutral oscillator readings with RSI at 63.03 suggesting balanced momentum. Recent news highlights oil market volatility from Middle East tensions and OPEC+ production decisions, creating both supply risks and price pressures.
The outlook remains cautiously optimistic given geopolitical tensions supporting oil prices, though G7 reserve releases and potential supply disruptions create conflicting forces. Key resistance sits at $150 with support at $146, making current levels critical for near-term direction amid volatile energy market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
